What have we learned from a decade of study and clinical use? Our experts review.

• Neovascularization: What is it and What Does it Mean?
  By Mariem Abdou, OD, and Joseph W. Sowka, OD
• Clinical Manifestations of VEGF-Mediated Retinal Disease
  By Julie Rodman, OD, MS, and Sherrol A. Reynolds, OD
• Stemming the Tide: How Anti-VEGF Therapies Confront Neovascularization
  By Christopher L. Suhr, OD
• The Optometrist’s Role in Anti-VEGF Therapy
  By Julie Torbit, OD and Brad Sutton, OD